This one is stronger than....
Apr 6, 2003
Dr.CC Thanks for that great answer on Strength and Power. Is there any info on which combo, Nevirapine, Abacavir 3TC. Or Nevirapine Tenofovir, 3TC is better at supressing the virus. Let us say the person is a drug virgin. Thanks, W.
Response from Dr. Cohen
Both are very good medications. Both have a low risk of lipodystrophy based on what we've seen over these years. Both are pretty easy to live on - although perhaps 5% do NOT tolerate abacavir due to an allergic reaction, while this is not a problem for tenofovir. Other than this - they appear to be similarly potent and able to control HIV. They both are powerful -- similar power to the two of them based on what we know. And if there is HIV rebound - these drugs are similar in terms of which mutations that might show up - with some reasonable debate as to which is better able to protect itself from resistance... and a hint that abacavir might be a bit better based on recent studies.
So I'd say at this point - that both are strong, powerful, and important options to consider for those that are, say, drug virgins...
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Hepatitis B How Long After Exposure Will It Show Up On A Test
- Hepatitis C And Body Odor
- Chances Of Getting Hiv By Having Sex One Time With A Positive Person
- Is Dna By Pcr Accurate After One Week Hiv?
- How Long Do Hiv Seroconversion Symptoms Last?
- How Long After A Person Is Infected With Hiv Do You Get Symptoms?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.